Buhat, Rodolfo .

HRN: 18-10-74  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/25/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/25/2026
03/04/2026
IV
2.25
Q8
Complicated Uti
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: